ELOX

ELOXX PHARMACEUTICALS INC

ELOX·29014R301·US·Common Stock-13D/G

ELOX (ELOXX PHARMACEUTICALS INC) is held by 10 institutional investors as of Q2 2026. Largest holders: Aberdeen Group plc ($5.6M), VANGUARD CAPITAL MANAGEMENT LLC ($1.1M), VANGUARD FIDUCIARY TRUST CO ($147,156). Net institutional sentiment: Bullish.

10
Holders
$6.8M
Total Value
100% (10)
Consensus
10 buying - 0 selling
13F: Insider & Congress: Updated regularly
ELOX

Smart Money Verdict

View all
Loading verdict
Held by 10 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistNANantahala Capital Management, LLC9.9%Aug 14, 2026
ActivistSASrinivas Akkaraju9.9%Aug 14, 2026
ActivistDODomicilium Capital Partners LLC20.0%Jun 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
400,000$5.6M0.0%+33.50%
37
New
78,680$1.1M0.0%+33.50%
38
New
10,602$147,1560.0%+33.50%
34
New
1,544$21,4310.0%+33.50%
29
New
718$9,9660.0%+33.50%
26
New
637$8,8420.0%+33.50%
26
New
126$1,7490.0%+33.50%
17
New
98$1,0000.0%+33.50%
17
New
12$1670.0%+33.50%
17
New
4$560.0%+33.50%
17
ELOXELOXELOXX PHARMACEUTICALS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used